In Brief: FDA reform
This article was originally published in The Rose Sheet
Executive Summary
FDA reform: The Cosmetic, Toiletry and Fragrance Association plans to submit comments following the April 11 Senate Labor & Human Resources Committee hearing on FDA. The hearing will include three panels of presentations from individuals interested in foods and medical devices; drugs, biologics and genetics; and patient advocacy groups. Public Citizen Health Research Group Director Sid Wolfe, MD, and Neil Kahanovitz, MD, Centers for Patient Advocacy, will testify along with Amgen CEO Gordon Binder. He will testify on behalf of both the Pharmaceutical Research and Manufacturers of America and the Biotechnology Industry Organization...